Kodamaea ohmeri: A rare yeast causing invasive infections in immunocompromised patients

J Infect Dev Ctries. 2024 Apr 30;18(4):636-639. doi: 10.3855/jidc.18517.

Abstract

Introduction: Kodamaea ohmeri is a rare, recognized pathogen that has previously been isolated from environmental sources. The patients commonly affected by this yeast include immunocompromised as well as immunocompetent patients having several associated risk factors.

Methodology: We report three cases in which K. ohmeri was isolated from blood using Bact T/ALERT. Identification was carried out by MALDI-TOF MS (Vitek-MS, BioMérieux, Marcy-l'Etoile, France) in addition to color characteristics on chromogenic media. The patients had diminished immune response on account of a multitude of comorbidities.

Results: K. ohmeri can be misidentified as Candida tropicalis, Candida albicans, or Candida hemolounii by conventional methods; correct and timely identification can be achieved by MALDI-TOF MS. Antifungal susceptibility breakpoints for K. ohmeri are currently not defined. An Echinocandin was added to the treatment regimen of all three of the cases.

Conclusions: Identification of K. ohmeri using conventional methods is difficult and unusual yeasts should be carefully observed, especially upon prolonged incubation.

Keywords: Kodamaea ohmeri; fungemia; immunocompromised.

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Antifungal Agents* / pharmacology
  • Antifungal Agents* / therapeutic use
  • Female
  • Humans
  • Immunocompromised Host*
  • Invasive Fungal Infections / diagnosis
  • Invasive Fungal Infections / drug therapy
  • Invasive Fungal Infections / microbiology
  • Male
  • Microbiological Techniques
  • Middle Aged
  • Saccharomycetales* / drug effects
  • Saccharomycetales* / isolation & purification
  • Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization*

Substances

  • Antifungal Agents